Supplemental material
Epigenetics
Volume 7, 2012 - Issue 11
Open access
721
Views
62
CrossRef citations to date
0
Altmetric
Research Paper
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Kim Andresen Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway; Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
, Kirsten Boberg Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Section of Gastroenterology; Department of Transplantation Medicine; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
, Hege Vedeld Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
, Hilde Honne Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
, Merete Hektoen Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
, Chrisopher Wadsworth Hepatology and Gastroenterology Section; Division of Diabetes, Endocrinology and Metabolism; Department of Medicine; Imperial College London; London, UK
, Ole Clausen Department of Pathology; Division of Diagnostics and Intervention; Oslo University Hospital; Oslo, Norway
, Tom Karlsen Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Section of Gastroenterology; Department of Transplantation Medicine; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
, Aksel Foss Section for Transplantation Surgery; Department of Transplantation Medicine; Division of Cancer Medicine, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Institute of Clinical Medicine; University of Oslo; Oslo, Norway
, Øystein Mathisen Section for Hepatopancreatic and Biliary Surgery; Department of Gastrointestinal Surgery; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway
, Erik Schrumpf Norwegian PSC Research Center; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Section of Gastroenterology; Department of Transplantation Medicine; Division of Cancer, Surgery and Transplantation; Oslo University Hospital; Oslo, Norway; Institute of Clinical Medicine; University of Oslo; Oslo, Norway
, Ragnhild Lothe Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, Norway
& Guro E. Lind Department of Cancer Prevention; Institute for Cancer Research; Oslo University Hospital, The Norwegian Radiumhospital; Oslo, Norway; Centre for Cancer Biomedicine; University of Oslo; Oslo, NorwayCorrespondence[email protected]
show all
Pages 1249-1257
|
Received 25 Jul 2012, Accepted 12 Sep 2012, Published online: 14 Sep 2012
Related Research Data
DNA Hypermethylation of MAL: A Promising Diagnostic Biomarker for Colorectal Tumors
Source:
Elsevier BV
Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature.
Source:
SAGE Publications
Circulating markers of biliary malignancy: opportunities in proteomics?
Source:
Elsevier BV
Serum and bile markers for cholangiocarcinoma.
Source:
Georg Thieme Verlag KG
Functional Epigenomics Identifies Genes Frequently Silenced in Prostate Cancer
Source:
American Association for Cancer Research (AACR)
Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Source:
Springer Science and Business Media LLC
Secreted antagonists of the Wnt signalling pathway
Source:
The Company of Biologists
Molecular Basis of Colorectal Cancer
Source:
Massachusetts Medical Society
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract.
Source:
Springer Science and Business Media LLC
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
Source:
Wiley
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.
Source:
Informa UK Limited
Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer
Source:
Public Library of Science (PLoS)
Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
Source:
Public Library of Science (PLoS)
DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism
Source:
American Association for Cancer Research (AACR)
Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
Source:
Cognizant, LLC
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.
Source:
Springer Science and Business Media LLC
Promoter CpG island hypermethylation during breast cancer progression
Source:
Springer Science and Business Media LLC
CpG island methylation in aberrant crypt foci of the colorectum.
Source:
American Society for Investigative Pathology. The Journal's web site is located at http://www.amjpathol.org
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Source:
Ovid Technologies (Wolters Kluwer Health)
An OMIC biomarker detection algorithm TriVote and its application in methylomic biomarker detection.
Source:
Future Medicine Ltd
Long Term Transcriptional Reactivation of Epigenetically Silenced Genes in Colorectal Cancer Cells Requires DNA Hypomethylation and Histone Acetylation
Source:
Public Library of Science (PLoS)
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients
Source:
Informa UK Limited
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
Source:
Elsevier BV
Genome-wide analysis of DNA methylation and the gene expression change in lung cancer.
Source:
International Association for the Study of Lung Cancer.
Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.
Source:
Springer Nature
CIMP IN COLORECTAL CANCER PATIENTS
Source:
Wiley
The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma
Source:
Public Library of Science (PLoS)
The fundamental role of epigenetic events in cancer
Source:
Springer Science and Business Media LLC
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.